RFP-Human Kidney Carcinoma cells (A498)

cAP-0075RFP

RFP-Human Kidney Carcinoma cells (A498)

1323.15 €

ALHC023-RFP

RFP-Human Kidney Carcinoma cells (A498)

400.3 €

ABC-RC217D

RFP-Human Gastric Carcinoma N87 Cells

Human Gastric Carcinoma N87 Cells (N87 cells) were established from the liver metastatic site of a male gastric carcinoma patient. RFP-Tagged Human Gastric Carcinoma N87 Cells (RFP-N87 cells) are selected from N87 cells after infected with lentiviruses expressing RFP with BSD. The cells can be cultivated with Universal Full Growth Medium and they have a minimum population doubling capacity > 12 when cultured following the detailed protocol described below.

Ask for quotation

ABC-FC0032

RFP-Human Retinal Microvascular Pericytes

HRMPCs are initiated by elutriation from dissociated normal human retinal tissue and transfected with RFP-Lentiviral particles at passage 2. Zeocin resistant RPF-HRMPCs were selected and shipped in frozen vials (the cells are provided @ passage 4-5). Pericytes growth medium is recommended for cell culture and these cells have an average population doubling capacity 6 when cultured following the detailed protocol described below.

Ask for quotation

ABC-FC0047

HighQC™ RFP-Human Adipose Derived Mesenchymal Stem Cell

HAdMSCs are isolated from lipoaspirate derived from white adipose tissue and demonstrated with spindle-shaped-, and fibroblast-like cells. RFP-HAdMSCs are puromycin resistant HAdMSCs after trandsfected with lentiviruses expressing RFP under the control of CMV protomer. Each lot of RFP-HAdMSCs is tested to ensure the cells can be passaged at least three times (i.e., approximately 9 to 10 population doublings) after thaw in complete growth media (Mesenchymal Stem Cell Growth Medium (MSCGM)), when cultured following the detailed protocol described below.

Ask for quotation

ABC-FC0044

HighQC™ RFP-Human Bone Marrow-Derived Mesenchymal Stem Cell

RFP-HBMMSCs are selected from puromycin resistant HBMMSCs after transfected with RFP expressing lentiviral particles. RFP-HBMMSCs are supplied in cryovials at passage 3-4. Each lot of RFP-HBMMSCs is tested to ensure the cells can be passaged at least for three times (i.e., approximately 9 to 10 population doublings) after thaw. RFP-HBMMSCs should be maintained in complete growth media (Mesenchymal Stem Cell Growth Medium (MSCGM)) following the detailed protocol described below.

Ask for quotation